Rheumatoid arthritis (RA) is a chronic, progressive, sustained inflammatory autoimmune disease associated with articular, extraarticular, and systemic effects. It is characterized by synovial inflammation, hyperplasia, leading to destruction of articular cartilage, bone erosion, and ultimately permanent deformities. Conventional treatments for RA include non-steroidal anti-inflammatory drugs, disease modifying antirheumatoid drugs, corticosteroids, and biological agents. All these therapeutic agents are associated with one or more side-effects, and none of the available treatments are able to achieve the ultimate therapeutic goal, i.e., drug-free remission. Herbal remedies are alternative source to relieve symptoms in patients having RA as well as to overcome the drawbacks associated with present treatment methods. A study conducted by the World Health Organization had reported that about 80% of world's population relies on traditional medicine. More than 450 plants belonging to 100 families are used traditionally in management of arthritis. Some of the important natural compounds reported toexhibit anti-arthritic potential includes anthroquinone (Aloe barbadensis), with anolides (Withania somnifera), terpenes (Zingiber officinale, Boswellia serrata), polyphenols (Camellia sinensis), stilbene (Vitis vinifera, Tripterygium wilfordi). Although a number of herbal medicines are recommended for RA, further research is required to investigate their safety, efficacy, and potential drug interactions.
INTRODUCTION

R
heumatoid arthritis (RA), a complex autoimmune inflammatory disorder, affects multiple joints of the body in a systematic manner.
[1] Initially, there is a chronic inflammation of synovial membrane which often leads to articular cartilage destruction, bone erosion, and permanent deformity. [2, 3] RA commonly affects the synovial-lined joints of feet, wrists, and knees, as well as cervical spine, shoulders, and hips. [4] The destruction of cartilage and bones is due to proliferation of synovium membrane which results in formation of pannus, i.e., the hypertrophied synovium. [5] Radiologic manifestations of such damage appear as loss of joint space and juxta-articular bone erosion. RA may have other systemic manifestations such as bone marrow alteration, comorbidities (pericarditis, osteoporosis, and lung disease), and psychosocial (depression and cognitive dysfunction) effects. [6] According to the World Health Organization (WHO), the prevalence of RA is estimated to be 0.5-1% worldwide, with women at three to five times more risk than men. [7] RA can start at any age; however, the mean age of onset is 40-60 years. Furthermore, people suffering from RA have diminished functioning and shortened life expectancy up to 5-10 years; however, it also depends upon severity of disease and genetic factors. [8] Exact cause of the disease is not clear precisely but hormonal, genetic, and environmental factors are important contributors in the development of disease. [9] RA is immune cell-mediated disease with progressive nature and is initiated and promoted by release of inflammatory cytokines by macrophages, B-cells, and T-cells. [10] The various proinflammatory cytokines involved in articular cartilage destruction are tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), IL-6, IL-8, granulocyte-macrophage colony-stimulating factor, and transforming growth factor-β (TGF-β). [11] Degrading enzymes secreted by fibroblast-like synoviocytes and macrophages play a key role in cartilage and bone destruction. [6] Elevated levels of vasoactive amines, arachidonic acid metabolites, proinflammatory cytokines, and neuropeptides activate the RA synovium. [11] McInnes and Schett reported production of autoantibody (rheumatoid factor and anti-citrullinated protein antibody). [4] The HLA-DR4 allele is also an important genetic factor in development and severity of disease. [7] The current review presents detail discussion on various agents used for treatment of RA and role of herbal drugs in treatment and cure of RA.
DRUGS USED IN TREATMENT OF RA
The goals of currently used antirheumatic drugs are to reduce pain and swelling, delay the progression of disease, minimize the disability, and ultimately improving patient life and expectancy. [12] Most of these objectives are achieved by combination of non-steroidal antiinflammatory drugs, disease modifying antirheumatic drugs, corticosteroids, and biological agents. In addition to conventional therapies, some unconventional therapies such as superoxide dismutase, antisense oligonucleotide, boron neutron capture therapy, and radioisotopes have been explored for the management of arthritis. [13] The various classes of drugs used for treatment of RA along with their molecular targets and complications have been summarized in the Table 1 .
HERBAL PRODUCTS
Herbal products are being used worldwide for various ailments. A number of natural products including flavonoids, terpenes, quinones, catechins, alkaloids, anthocyanins, and anthoxanthins modulate inflammatory response and hence are considered as gold mine for treatment of RA. They act by multiple mechanisms such as suppression of TNF-α, IL-1β, cyclooxygenase (COX), lipoxygenase (LOX), nuclear factor-κB (NF-κB), adhesion molecules, and metalloproteinases. [25, 26] Curcumin Curcumin (Curcuma longa) possesses various biological activities such as anti-inflammatory, hepatoprotective, antibacterial, antidiabetic, antidepressant, analgesic, and anticarcinogenic. [27, 28] The anti-inflammatory action of curcumin is attributed to inhibition of LOX, suppression of activation of NF-β, TNF-α, molecular adhesion, and inhibition of upregulation of matrix metalloproteinase (MMP-9) mRNA. It also promotes suppression of expression of TNF-α-induced MMP-13 in chondrocytes. [29] Various in vivo and in vitro studies have been carried out to explore the antiarthritic potential of curcumin. In vivo evaluation of curcuminoid was found to reduce both acute and chronic inflammation by 75% and 68%, respectively. [30] Oral administration of curcumin provides symptomatic relief in exercise-induced muscle damage due to its anti-inflammatory property.
[31]
Guggulosterone
Guggul is a common name for Commiphora species and contains a bioactive oleo-gum-resin which is responsible for various pharmacological activities. Gum contains various constituents such as guggulosterone [4,17(20) NSAIDs: Non-steroidal anti-inflammatory drugs, remission, DMARDs: Disease modifying anti-rheumatoid drugs, TNF-α: Tumor necrosis factor-α, IL: Interleukin, COX: Cyclooxygenase, CVS: Chorionic villus sampling diterpene, Gallic acid, and flavanoids. The resin has been used for the treatment of various types of ailments including cardiovascular disease, ulcer, diabetes, cancer, leprosy, obesity, and RA. [32] [33] [34] Guggulosterone act by inhibiting MAP kinase, which further inhibit NF-ĸB, and also by downregulating expression of cytokines such as IFN-γ, IL-12, IL-1β and nitric oxide (NO). [35] In vivo anti-inflammatory activity of guggulosterone was found to be comparable to phenylbutazone and ibuprofen in rats. [36, 37] Resveratrol Resveratrol (trans-3,4',5-trihydroxystilbene), a polyphenolic compound, has been found in various plants such as grapes, peanuts, mulberries, and rhubarb. It exhibits various health benefits such as antiaging, antioxidant, antihypercholesterolemic, antiarthritis, antidiabetic, antiviral, and neuroprotective. [38] The role of resveratrol in treatment of joint disorder is due to suppression of NF-ĸB, c-Jun N-terminal kinase (JNK)/extracellular signal-regulated kinase (ERK)-activator protein-1 (AP-1), iNOS-NO, COX-2-PGE 2 , MMP-13, TNF-α, and IL-1β genes. [39, 40] Withanolides Withanolides (Ashwaganda), obtained from extract of Withania somnifera, are reported to have analgesic, anti-inflammatory, antibacterial, immunomodulatory, anticancer, diuretic, antiulcer, antidiabetic, and antiarthritic properties. [41] The in vivo antiarthritic potential of aqueous extract of W. somnifera roots was evaluated in rats and was found to reduce anticyclic citrullinated peptide antibody (a-CCP), collagen Type II antibody (a-CII), inflammatory marker such as C-reactive protein (CRP), lipid peroxidation, and glutathione-Stransferase activity. [42] With anolides also inhibit NF-ĸB and NF-ĸB-regulated gene expression. The clinical evaluation of W. somnifera extract at two different doses (250 mg, 125 mg) has been found to reduce inflammation significantly in dosedependent manner and was devoid of any side effects. [43] Boswellic acid (BA) BA (Boswellia serrata, Burseraceae), pentacylclic terpene, is found in plants in the forms of various derivatives such as acetyl-11-keto-BA and 11-keto-BA. [44] Therapeutically BA and its derivatives are used in various ailments such a sulcerative colitis, cancer, hepatitis, inflammation, pain, cough, bacterial infection, and osteoarthritis. [45] In preclinical evaluation, BA was reported to reduce cartilage loss, synovitis, and osteophyte formation and hence has beneficial role in osteoarthritis and other joint disorder. [46] Clinical investigation of B. serrata extract was found to provide statistically significant improvement in patients suffering osteoarthritis and was well tolerated with minor gastric disturbance. [47] The antiarthritic activity of BA is due to inhibition of NF-ĸB, COX-2, LOX-5.
[ 48] Procyanidine Procyanidine (Cinnamomum zeylenicum, Lauraceae), a polyphenol derivative, has been explored in various pharmacological conditions such as atherosclerosis, diabetes, fungal infection, inflammation, alzheimer disease, and arthritis. [49, 50] Type-A procyanidine polyphenols are reported to have immunomodulatory and anti-inflammatory potential without analgesic activity in both in vitro and in vivo studies. [51] In another study, C. zeylenicum extract was found to reduce inflammation and arthritis in rats by suppressing intracellular release of TNF-α in dose-dependent manner and; hence is an effective remedy for treating RA. [52, 53] 
Shagoal
Conventionally, ginger (Zingiber officinale) is used in treatment of various diseases such as pain, arthritis, cough, hepatotoxicity, oxidative stress, and cardiovascular problems.
[54] The major phytochemical constituents of ginger are 6-,8-,10-gingerol, 6-,8-,10-shagaol and zingiberine. [55] The antiarthritic activity of shagoal is due to suppression of IL-1 β, IL-6, TNF-α, and INF-γ. [56, 57] The efficacy and tolerability of ginger in management of arthritis has been tested in patients with knee joint pain. Ginger powder exhibited significant reduction in arthritis index and visual analog scale scores and it is attributed to reduced production of NO and CRP. [58, 59] 6-shagoal is most potent antioxidant and anti-inflammatory agent among other shagaols and gingerols. [60] Ginger essential oil, a secondary metabolite of ginger, also prevented chronic joint inflammation, and granuloma formation. The antirheumatic effect of ginger are not only due to phenolic compounds (gingerol and shagoal) but also attributable to secondary metabolites. [61] The chemicals structures of some of the active constituents responsible for anti-inflammatory activity have been given in Figure 1 .
Others
In addition to above-discussed natural products, several other herbal compounds are found to have antiarthritic activity. Clinical trials have been carried out with several natural products and their combination preparation. The anti-inflammatory activity of extract of ten herbs, including Japanese creeper, Chinese honeylocust spine, datchmanspipe herb, pubescent angelica, garden balsam, antonese buttercup, giant typhonium tuber, euphorbia, semen hyoscyami, and sesame oil was investigated in oxazolone-induced inflammation in mice. It has been observed that extract of these herbs has ability to reduce inflammation by inhibiting TNF-αlevel. [25] Black sage, Salvia mellifera, is employed in form of topical preparation for treatment of pain associated with RA. [26] Two clinical studies have been carried out to investigate efficacy of borage seed oil, Borago officinalis, for RA. The active constituent of Borago officinalis is γ-linolenic acid which is responsible for significant improvement in joint pain and swelling. [62] The antiarthritic potential of ethyl acetate fraction of chloroform extract of Barleria prionitis was investigated in formaldehyde-induced and Freund's complete adjuvantinduced chronic arthritis in rats. Significant inhibition of oedema formation in dose-dependent manner was observed. [63] The safety and efficacy of ethanol/ethyl acetate extract of Tripterygium wilfordi hook F were evaluated in rheumatic patients unresponsive to conventional therapy. A dosedependent effect was seen in the rheumatic patients and the extract was well tolerated in therapeutic dosages. [64, 65] Anti-inflammatory activity of active constituent, methyl ferulate (MF) from Stemona tuberose, was tested by measuring cytokine release, NO generation, expression of COX-2, and protein kinase pathway. MF strongly inhibited release of proinflammatory cytokines IL-6, TNF-α, IFN-γ but has no effect on IL-10. MF is also a potent inhibitor of nitrogen activated kinase. [66] Therapeutic efficacy of petroleum ether extract of Celastrus paniculatus has been investigated in adjuvant-induced arthritis in rats. Arthritic severity was evaluated by arthritis score, paw volume, joint thickness, knee flexion, body weight, and index of thymus and spleen and rate of motility. C. paniculatus alleviated arthritic progression due to significant suppression of overproduction of inflammatory cytokines, oxidative stress markers, and cellular enzyme levels. [67] The antiarthritic activity of three herbal extract, namely, modified Huo-luo-xiao-ling dan, Celastrus aculeatus, and green tea (Camellia sinensis) have been tested in adjuvantinduced arthritis in rats. The reduction in disease severity is due to inhibition of inflammatory cytokines such as IL-1β, IL-6, IL-17, NO, MMP-9, monocyte chemotactic protein-1 (MCP-1), mediators of bone modeling (receptor activator of nuclear factor-κB ligand (RANKL)) and TNF-α. [68] The antiarthritic activity of various herbal products has been summarized in Table 2 .
Even though, a large number of trials have been carried out with various natural products, they could not find clinical efficacy as in most of the cases comparison with standard drugs have not been made. Hence, more clinical trials should be carried out to access potential of herbal products in arthritis. In case of RA, comparison should be done with MTX because it is the first line of drug used for treating RA. In addition, the safety profile of natural products should be accessed in patients with significant adverse effects with conventional therapies. Moreover, identification of active constituent of herbal products could help in identifying better molecules. 
CONCLUSION
Although many conventional and non-conventional treatments for arthritis have been identified, all of these are associated with few limitations such as long-term efficacy, safety, and cost. Herbal remedies are alternative drugs to relieve symptoms in RA patients as well as to overcome the drawbacks associated with present treatment methods. A study conducted by the WHO had reported that about 80% of world's population relies on traditional medicine. More than 450 plants belonging to 100 families are used traditionally in the management of arthritis.
Plant-derived products are much promising agent for RA but still extensive investigation is required to prove their usefulness. Although a number of herbal medicines are recommended for RA, further research is required to investigate their safety, efficacy, and potential drug interactions. NF-ĸB: Nuclear factor-ĸB, AMs: Adhesion molecules, MMP-9: Matrix metalloproteinase-9, LOX: Lipoxegenase, IFN-α: Interferon-γ, ICAM-1: Intracellular adhesion molecule-1
